Preview

Humans and their health

Advanced search

Development of methods for determining the content of residual organic solvents in a new pharmaceutical substance of 3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane-carboxylic acid

https://doi.org/10.21626/vestnik/2022-3/09

Abstract

Objective. Organic solvents, which often have toxic and/or carcinogenic properties, are used at all stages of the production of pharmaceutical substances - synthesis, isolation and purification - and are not completely removed after the completion of the technological process. The presence of even extremely small amounts of such compounds in medicines can be dangerous for patients. The article presents the results of the development of a method for determining the content of residual organic solvents (ROS) - ethanol, toluene and dimethylformamide - in a new active pharmaceutical ingredient (API) 3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane-carboxylic acid by gas chromatography. Materials and methods. Static vapor phase analysis was used to identify and to quantify residual organic solvents. It was determined by the internal standard method using a Shimadzu GC-2014ATF/SPL gas chromatograph with an AOC-6000Plus autosampler; PID detection. Isobutyl alcohol was used as an internal standard. Results. The developed method was used to determine the content of residual organic solvents in the validation series of the new pharmaceutical substance 3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane-carboxylic acid. The method was validated in accordance with the requirements of the State Pharmacopoeia of the Russian Federation. Conclusion. The developed method is suitable for further use in quality control in the production of 3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane-carboxylic acid.

About the Authors

Anton V. Metelev
LLC “BELPHARMAMED”
Russian Federation

chemical analyst of the quality control laboratory, LLC “BELFARMAMED”, Belgorod, Russian Federation



Valentina S. Kazakova
LLC “BELPHARMAMED”; Belgorod national research university (BNRU)
Russian Federation

Cand. Sci. (Pharm.), Head of the quality control department, LLC “BELFARMAMED”, Belgorod, Russian Federation; Associate Professor at the Department of Pharmaceutical Technology, BNRU, Belgorod, Russian Federation



Dariya A. Fadeeva
Belgorod national research university (BNRU)
Russian Federation

Cand. Sci. (Pharm.), Associate Professor at the Department of Pharmaceutical Technology, BNRU, Belgorod, Russian Federation



Andrey A. Buzov
LLC “BELPHARMAMED”
Russian Federation

Cand. Sci. (Tech.), Deputy Director, LLC “BELFARMAMED”, Belgorod, Russian Federation



Vladimir P. Chuev


References

1. Pokrovskij M. V., Chuev V.P., Buzov A.A., Kovalenko S.N., Kravchen-ko A.V, authors; LLC "BELFARMAMED", assignee. 3-(1H-benzimidazol-2-yl)-1,2,2-trimethyl cyclopentancarbonic acid with cardioprotective activity.Russian Federation patent RU 2645356. 2018 Feb 21 (in Russ.). EDN: ZEDDHV

2. Chuev V.P., Buzov A.A., Kovalenko S.N., Merzlikin C.I., Strygol C.Y., authors; LLC "VladMiVa", assignee. Pharmaceutical antidiabetic composition based on (+)-cis-3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane carboxylic acid.Russian Federation patent RU 2624872. 2017 Jul 21 (in Russ.). EDN: WWFWNX

3. Metelev A.V., Kazakova V.S., Fadeeva D.A., Buzov A.A., Chuev V.P. Elaboration of techniques for quality control of a new active pharmaceutical substance of 3-(1h-benzimidazol-2-yl)-1,2,2-trimethyl cyclopentancarbonic acid. Medicine. 2022;10(1):19-31 (in Russ.). DOI: 10.29234/2308-9113-2022-10-1-19-31. EDN: AIATDX

4. Reid G.L. Residual solvents. In: Specification of Drug Substances and Products. Elsevier, 2020:345-365. DOI: 10.1016/B978-0-08-102824-7.00013-0

5. Sattineni S.R., Joseph A., Das S., Chaitainya B., Rao S. Method development and validation for the determination of residual solvents in racecadotril by gas chromatography. Current Pharmaceutical Analysis. 2021;17(9):1232-1239. DOI: 10.2174/1573412916999200819163552

6. Bawazeer S. Development and validation of chromatographic methods for the quantitative determination of toltrazuril and its residual solvents. Hail Journal of Health Sciences. 2020;2(1):9-18. DOI: 10.4103/1658-8312.347570

7. Chawla R.K., Koteswara Rao G.S.N., Kulandaivelu U., Panda S.P., Alavala R.R. Development and validation of a headspace gas chromatographic (HS-GC) method for determination of residual solvents in nitazoxanide API.Int J Res Pharm Sci. 2020;11(SPL4):1719-1727. DOI: 10.26452/ijrps.v11iSPL4.4362

8. Noorbasha K., Shaik A. Determination of residual solvents in paclitaxel by headspace gas chromatography. Futur J Pharm Sci. 2021;7(1):1-17. DOI: 10.1186/s43094-021-00186-7

9. Rao S.S., Vijayalakshmi A. Analytical method development and validation of glipizide to determine residual solvents by head space-gas chromatography. Research Journal of Pharmacy and Technology. 2021;14(5):2440-2444. DOI: 10.52711/0974-360X.2021.00429

10. Louati K., Mouna S., Fathi S. Development and Validation of a Separation and Quantification Method for Residual Solvents in Active Substances by Headspace Gas Chromatography. American Academic Scientific Research Journal for Engineering, Technology, and Sciences. 2018;41(1):57-75


Review

For citations:


Metelev A.V., Kazakova V.S., Fadeeva D.A., Buzov A.A., Chuev V.P. Development of methods for determining the content of residual organic solvents in a new pharmaceutical substance of 3-(1H-benzimidazol-2-yl)-1,2,2-trimethylcyclopentane-carboxylic acid. Humans and their health. 2022;25(3):81-92. (In Russ.) https://doi.org/10.21626/vestnik/2022-3/09

Views: 332


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1998-5746 (Print)
ISSN 1998-5754 (Online)